Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 71209-095

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 71209-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-12-5mg-30-tab (Cont Label 12 5mg 30 Tab)

Paroxetine Extended-Release Tablets 12.5 mg film-coated tablets in a carton label from Cadila Pharmaceuticals Limited. The label states a quantity of 30 tablets, Rx only, with storage instructions and a note to dispense the accompanying Medication Guide. The NDC number 71209-094-01 is shown along with manufacturer details and warnings to keep the medication out of reach of children.*

FDA Label Image

Cont-label-12-5mg-500-tab (Cont Label 12 5mg 500 Tab)

Paroxetine Extended-Release Tablets label showing 12.5 mg strength in film-coated, extended-release oral tablet form. The label includes storage instructions, dispensing guidelines, and contains 500 tablets per package. The manufacturer is Cadila Pharmaceuticals Limited. The label also features a barcode and indicates the product is prescription only.*

FDA Label Image

Cont-label-25mg-30-tab (Cont Label 25mg 30 Tab)

Paroxetine Extended-Release Tablets 25 mg film-coated, extended-release oral tablets by Cadila Pharmaceuticals Limited. The label displays the dosage strength (25 mg) prominently with a package size of 30 tablets. It includes storage instructions, manufacturer information, and a barcode on a white background with red accents.*

FDA Label Image

Cont-label-25mg-500-tab (Cont Label 25mg 500 Tab)

Label for Paroxetine Extended-Release Tablets 25 mg by Cadila Pharmaceuticals Limited. The film-coated, extended-release oral tablets come in a package of 500 tablets. The label includes storage instructions, dosage warnings, and pharmacist dispensing advice, along with a barcode and manufacturer details in Ahmedabad, Gujarat, India.*

FDA Label Image

Cont-label-37-5mg-30-tab (Cont Label 37 5mg 30 Tab)

Paroxetine Extended-Release Tablets 37.5 mg in a packaging label showing a 30-tablet count. The label indicates it is a prescription drug, film-coated, extended-release oral tablets manufactured by Cadila Pharmaceuticals Limited. The label includes storage instructions, usage warnings, barcode, and the NDC code 71209-096-01.*

FDA Label Image

Cont-label-37-5mg-500-tab (Cont Label 37 5mg 500 Tab)

Paroxetine Extended-Release Tablets 37.5 mg film-coated, oral dosage form, in a 500 tablet bottle. Label indicates the product is manufactured by Cadila Pharmaceuticals Limited, Gujarat, India. The label includes storage instructions, dispensing guidance, and a barcode. The strength, 37.5 mg, is prominently displayed on the front.*

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic graph illustrating the fold change and 90% confidence intervals of the Cmax and AUC values for various interacting drugs relative to a reference. Drugs listed include Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg, showing their relative impact on drug exposure.*

FDA Label Image

Fig2 (Fig2)

A forest plot chart showing the pharmacokinetic interactions of various drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam) on Cmax and AUC relative to a reference. The X-axis measures fold change with 90% confidence intervals, ranging from 0 to 2, illustrating variability in drug concentrations.*

FDA Label Image

Fig3 (Fig3)

A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) of Paroxetine extended-release tablets in various population subgroups, including renal impairment (mild to severe), hepatic impairment, different age doses (>65 years), and gender (males), with change relative to reference on a logarithmic scale.*

FDA Label Image

Paroxetine-strc-spl (Paroxetine Strc Spl)

Chemical structure diagram of Paroxetine hydrochloride hemihydrate, showing the molecular arrangement including fluorophenyl, piperidine, and methylenedioxyphenyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.